RE:New Press Release - Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMOIn Matt we trust! If we look at the markets reaction after two NR this morning. Matt where are the deal and multiple phase 3 announcement? GL